Federal award
AMERISOURCEBERGEN DRUG CORP
SPE2DX22D0051
Contract vehicle (IDV)IDV: ceiling is not spending
Obligated and Ceiling
- Obligated (net)
- $0.00
- Vehicle ceiling (not spending)
- $28,865,568,773.13
- Current value
- —
- Gross positive obligations
- $0.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- AMERISOURCEBERGEN DRUG CORP · KABZK8W6PQT3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CENCORA GLOBAL CONSULTING SERVICES US CORP · GTXTRMLFL9U7
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2DX
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- SPE2DX22D0051
- Award type code
- B
- Actions
- 13 · Jul 14, 2022 to Oct 7, 2025
- Why it is listed
- contract vehicle (IDV)
Action History13
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Oct 7, 2025 | FY2026 | P00012 | B | $0.00 | — |
| Oct 2, 2025 | FY2026 | P00011 | B | $0.00 | — |
| Sep 10, 2025 | FY2025 | P00010 | B | $0.00 | — |
| Jul 8, 2025 | FY2025 | P00009 | B | $0.00 | — |
| Dec 5, 2024 | FY2025 | P00008 | G | $0.00 | — |
| Nov 14, 2024 | FY2025 | P00007 | D | $0.00 | — |
| Sep 4, 2024 | FY2024 | P00006 | B | $0.00 | — |
| Jul 16, 2024 | FY2024 | P00005 | D | $0.00 | — |
| May 21, 2024 | FY2024 | P00004 | D | $0.00 | — |
| Aug 15, 2023 | FY2023 | P00003 | D | $0.00 | — |
| Jul 10, 2023 | FY2023 | P00002 | D | $0.00 | — |
| Oct 11, 2022 | FY2023 | P00001 | B | $0.00 | — |
| Jul 14, 2022 | FY2022 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.